FLGT Fulgent Genetics Inc

Price (delayed)

$102.75

Market cap

$2.49B

P/E Ratio

47.57

Dividend/share

N/A

EPS

$2.16

Enterprise value

$2.44B

Sector: Healthcare
Industry: Diagnostics & Research

Highlights

The company's equity has surged by 115% QoQ
FLGT's gross margin is up by 24% year-on-year and by 24% since the previous quarter
FLGT's quick ratio has dropped by 67% year-on-year and by 46% since the previous quarter

Key stats

What are the main financial stats of FLGT
Market
Shares outstanding
24.27M
Market cap
$2.49B
Enterprise value
$2.44B
Valuations
Price to earnings (P/E)
47.57
Price to book (P/B)
12
Price to sales (P/S)
16.78
EV/EBIT
39.65
EV/EBITDA
37.9
EV/Sales
18.09
Earnings
Revenue
$135.12M
EBIT
$61.63M
EBITDA
$64.48M
Free cash flow
-$7.05M
Per share
EPS
$2.16
Free cash flow per share
-$0.32
Book value per share
$8.56
Revenue per share
$6.12
TBVPS
$11.21
Balance sheet
Total assets
$247.31M
Total liabilities
$60.36M
Debt
$2.74M
Equity
$186.96M
Working capital
$137.88M
Liquidity
Debt to equity
0.01
Current ratio
3.39
Quick ratio
2.87
Net debt/EBITDA
-0.78
Margins
EBITDA margin
47.7%
Gross margin
69.2%
Net margin
35.3%
Operating margin
47.2%
Efficiency
Return on assets
36.6%
Return on equity
43.6%
Return on invested capital
64.6%
Return on capital employed
32.5%
Return on sales
45.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

FLGT stock price

How has the Fulgent Genetics stock price performed over time
Intraday
-6.91%
1 week
-25.05%
1 month
46.79%
1 year
488.83%
YTD
97.22%
QTD
97.22%

Financial performance

How have Fulgent Genetics's revenue and profit performed over time
Revenue
$135.12M
Gross profit
$93.45M
Operating income
$63.84M
Net income
$47.71M
Gross margin
69.2%
Net margin
35.3%
FLGT's gross margin is up by 24% year-on-year and by 24% since the previous quarter

Growth

What is Fulgent Genetics's growth rate over time

Valuation

What is Fulgent Genetics stock price valuation
P/E
47.57
P/B
12
P/S
16.78
EV/EBIT
39.65
EV/EBITDA
37.9
EV/Sales
18.09
The company's equity has surged by 115% QoQ
FLGT's P/S is 189% above its 5-year quarterly average of 5.8 and 136% above its last 4 quarters average of 7.1

Efficiency

How efficient is Fulgent Genetics business performance

Dividends

What is FLGT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FLGT.

Financial health

How did Fulgent Genetics financials performed over time
FLGT's quick ratio has dropped by 67% year-on-year and by 46% since the previous quarter
FLGT's current ratio has dropped by 63% year-on-year and by 46% since the previous quarter
Fulgent Genetics's debt is 99% less than its equity
FLGT's debt to equity has dropped by 80% year-on-year and by 67% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.